Alpha 2.0
Login Register
» Authors » Pierre Housset

Pierre Housset

Explore the profile of Pierre Housset including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 235
Followers 0
Related Specialties
Nephrology
Infectious Diseases
General Medicine
Top 10 Co-Authors
Dogan-Firat Bozman
Agathe Pardon
Valerie Caudwell
Nathalie Vittoz
Latifa Hanafi
Sabah Kubab
Anne-Laure Faucon
Albert Trinh-Duc
Geraldine Gaube
Fabrice Carrat
Published In
J Nephrol
AIDS
Am J Kidney Dis
J Infect
Nephrol Dial Transplant
Affiliations
Soon will be listed here.
Recent Articles
1.
Bivalent vaccination against COVID-19 can trigger a humoral response in immunocompromised patients who receive monoclonal antibody prophylaxis
Housset P, Bouhelier C, Pardon A, Hanafi L, Vittoz N, Bozman D, et al.
J Nephrol . 2023 Jul; 36(6):1719-1721. PMID: 37410357
No abstract available.
2.
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir
Martin-Blondel G, Marcelin A, Soulie C, Kaisaridi S, Lusivika-Nzinga C, Zafilaza K, et al.
Clin Microbiol Infect . 2022 Dec; 29(4):543.e5-543.e9. PMID: 36586513
Objectives: Our aim was to compare the clinical and virological outcomes in Omicron BA.1- and BA.2-infected patients who received sotrovimab with those in patients who received nirmatrelvir for the prevention...
3.
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2
Martin-Blondel G, Marcelin A, Soulie C, Kaisaridi S, Lusivika-Nzinga C, Dorival C, et al.
J Infect . 2022 Jul; 85(4):e104-e108. PMID: 35803386
No abstract available.
4.
Humoral response after a fourth "booster" dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients
Housset P, Kubab S, Hanafi L, Pardon A, Vittoz N, Bozman D, et al.
Kidney Int . 2022 Apr; 101(6):1289-1290. PMID: 35421509
No abstract available.
5.
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
Housset P, Kubab S, Pardon A, Vittoz N, Bozman D, Hanafi L, et al.
J Nephrol . 2022 Feb; 35(3):783-785. PMID: 35192157
No abstract available.
6.
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
Bensouna I, Caudwell V, Kubab S, Acquaviva S, Pardon A, Vittoz N, et al.
Am J Kidney Dis . 2021 Sep; 79(2):185-192.e1. PMID: 34508833
Rationale & Objective: Recent studies showed that antibody titers after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the dialysis population are diminished as compared with the general...
7.
Biomarkers of IgA vasculitis nephritis in children
Pillebout E, Jamin A, Ayari H, Housset P, Pierre M, Sauvaget V, et al.
PLoS One . 2017 Dec; 12(11):e0188718. PMID: 29190714
Henoch-Schönlein purpura is a systemic vasculitis characterized by IgA deposits, which target the skin, joints, and kidneys, among other organs. In children, prognosis is often good but little is known...
8.
Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort
Berthelot L, Jamin A, Viglietti D, Chemouny J, Ayari H, Pierre M, et al.
Nephrol Dial Transplant . 2017 Nov; 33(9):1579-1590. PMID: 29126311
Background: Henoch-Schönlein purpura, more recently renamed immunoglobulin A vasculitis (IgAV), is a systemic vasculitis characterized by IgA deposits. The current markers used to assess IgAV inaccurately evaluate the risk of...
9.
Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient
Izzedine H, Kheder-Elfekih R, Housset P, Sarkozy C, Brocheriou I, Deray G
AIDS . 2009 Jan; 23(4):544-5. PMID: 19165085
No abstract available.